The DOI matches its Crossref record.
Long-term treatment of acromegaly with bromocriptine.
Open accessAbstract
Seventy-three patients with active acromegaly were treated for three to 25 months with bromocriptine 10-60 mg/day. Seventy-one patients showed symptomatic and objective clinical improvement. This included reduction in excessive sweating, hand and foot size, and the number of headaches; improved facial appearance; and increased energy and libido. Abnormal visual fields became normal in two patients, one of whom had concomitant radiotherapy. Mean circulating growth hormone levels, obtained by averaging serial samples through the day, fell by more than 7 microng/l or became undetectable in 58 patients (79%) but did not reach normal values: only 15 patients had mean levels on treatment of 5 microng/l or less. Twenty-three patients were diabetic before treatment, and glucose tolerance became normal in 15 and improved in a further five. Provided the drug was started slowly side effects were minor when compared with the considerable clinical benefit obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Melmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
Clemmons, D. R., Van Wyk, J. J., Ridgway, E. C., Kliman, B., Kjellberg, R. N., & Underwood, L. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012102 · Cited by 364
Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience
Ahmed, Elsheikh, Stratton, Page, Adams, & Wass (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00760.x · Cited by 291
Metadata
- Authors
- Wass, J. A., Thorner, M. O., Morris, D. V., Rees, L. H., Mason, A. S., Jones, A. E., & Besser, G. M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1977-04-02
- Volume
- 1
- Issue
- 6065
- Pages
- 875-878
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W2091019371
- Cited by
- 242
- References
- 0
- FWCI
- 26.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term treatment of acromegaly with bromocriptine. https://app.cochat.ai/papers/10.1136/bmj.1.6065.875
- The paper
- Wass, J. A., Thorner, M. O., Morris, D. V., Rees, L. H., Mason, A. S., Jones, A. E., & Besser, G. M. (1977). Long-term treatment of acromegaly with bromocriptine. BMJ. https://doi.org/10.1136/bmj.1.6065.875
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.